Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1CNS 1

Conditions

Brain Neoplasms 4Prostatic Neoplasms 3Neoplasms 3Breast Neoplasms 3Pancreatic Neoplasms 2Neoplasm Metastasis 2Carcinoma, Hepatocellular 2Uterine Cervical Neoplasms 1Pinealoma 1Parotid Neoplasms 1Oligodendroglioma 1Neuroendocrine Tumors 1Neuroectodermal Tumors, Primitive 1Multiple Sclerosis 1Meningioma 1Meningeal Neoplasms 1Medulloblastoma 1Lymphoma 1Liver Neoplasms 1Hypoxia 1Gynecologic Cancer 1Gliosarcoma 1Glioma 1Glioblastoma 1Ependymoma 1Digestive System Diseases 1Colorectal Neoplasms 1Choroid Plexus Neoplasms 1Astrocytoma 1

Interventions

pembrolizumab 155Gemcitabine 139Capecitabine 121Paclitaxel 118Fluorouracil 116Oxaliplatin 110Bevacizumab 104Nivolumab 97Leucovorin 97Docetaxel 92Cisplatin 89Irinotecan 87Carboplatin 84Radiosurgery 83Cyclophosphamide 70Cetuximab 70Magnetic Resonance Spectroscopy 68Trastuzumab 56Specimen Handling 56Biopsy 56Radiotherapy 55Ipilimumab 52Everolimus 48Pemetrexed 46Drug Therapy 45Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 43Doxorubicin 41Fulvestrant 38aldesleukin 37

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Neoplasm Metastasis × gadobutrol × Clear all
NCT02796729 2019-01-28

CEST- Glucose Enhanced MRI for Metastatic Brain Tumours

British Columbia Cancer Agency

Phase 2 Terminated
3 enrolled
CNS

Brain Neoplasms, Neoplasm Metastasis

NCT02036008 2014-01-14

Gadofosveset Trisodium (Ablavar, Gdfos) in Distinguishing Hemangiomas and Metastases: A Prospective Trial

Sunnybrook Health Sciences Centre

Phase NA Unknown
150 enrolled
Gastrointestinal

Liver Neoplasms, Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡